Human PC-3 prostate cancer cells were treated with TNF-α, a classical activator of p65/NF-κB. In the absence of TNF-α, cells exhibited prominent cytoplasmic staining of NF-κB while nuclear staining was not detected. Here, TNF is linked to prostate carcinoma.